SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Thursday reported a loss of $36.8 million in its fourth quarter.The Seattle-based company said it had a loss of 38 cents per share._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTIC at https://www.zacks.com/ap/CTIC